Video Experimental Relacionado
Updated: Jun 15, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Aprendizaje profundo balanceado en redes multi-ómicas identifica subgrupos moleculares del envejecimiento cerebral
Este estudio identificó cinco subgrupos moleculares distintos del envejecimiento cerebral utilizando un novedoso marco de integración multi-ómica informada por redes. Estos subgrupos revelan patrones biológicos dependientes de la etapa y ayudan a comprender la heterogeneidad de la enfermedad de Alzheimer.
Área de la Ciencia:
- Neuroscience
- Genomics
- Computational Biology
Sus antecedentes:
- Neurodegenerative diseases like Alzheimer's disease (AD) present significant heterogeneity, complicating diagnosis and treatment.
- High-dimensional, imbalanced multi-omics data integration with biological networks is a key methodological challenge.
Objetivo del estudio:
- To develop and validate a network-informed multi-omics integration framework for identifying molecular subgroups in brain aging.
- To characterize the molecular and neuropathological differences across identified subgroups.
Principales métodos:
- Developed a framework integrating multi-omics data (transcriptomics, proteomics, metabolomics) with brain networks from ROS/MAP cohorts.
- Utilized graph embedding (AD Atlas) and autoencoders to derive multi-omics expression scores for hierarchical clustering.
- Validated subgroup robustness and classifier performance in an independent cohort.
Principales resultados:
- Identified five molecular subgroups with distinct cognitive performance and neuropathological profiles.
- Demonstrated reliable subgroup discrimination using cross-validated classification of transcriptomic and proteomic data.
- Revealed stage-dependent biological patterns, including synaptic/immune activation, mitochondrial dysfunction, and proteostatic impairment.
Conclusiones:
- The framework successfully identified molecular subgroups of brain aging, offering insights beyond clinical diagnosis.
- A spectrum of disease progression was observed, from at-risk controls to typical Alzheimer's disease, differentiated by tau pathology.
- Identified subgroups include a reference control, a mixed pathology group, and stages of AD progression.
Más Videos Relacionados
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Videos de Conceptos Relacionados
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology